NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Provectus Biopharmaceuticals Inc (OTCQB: PVCT)
PVCT Technical Analysis
1.5
As on 24th Dec 2024 PVCT STOCK Price closed @ 0.12 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.13 & Buy for SHORT-TERM with Stoploss of 0.11 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PVCTSTOCK Price
Open | 0.12 | Change | Price | % |
High | 0.12 | 1 Day | 0.00 | 0.00 |
Low | 0.12 | 1 Week | -0.01 | -7.69 |
Close | 0.12 | 1 Month | 0.01 | 9.09 |
Volume | 50283 | 1 Year | 0.00 | 0.00 |
52 Week High 0.22 | 52 Week Low 0.06 |
OTCQB USA Most Active Stocks
FNMAS | 10.12 | 2.33% |
FMCKJ | 9.73 | 0.83% |
BMIX | 0.01 | % |
BTCWF | 0.10 | 150.00% |
ALPP | 3.56 | 0.00% |
ALPP | 3.56 | 0.00% |
NWBO | 0.31 | -3.12% |
VKIN | 0.23 | 0.00% |
FNMA | 2.65 | 0.76% |
LTSRF | 0.15 | -6.25% |
OTCQB USA Top Gainers Stocks
OTCQB USA Top Losers Stocks
PVCT Daily Charts |
PVCT Intraday Charts |
Whats New @ Bazaartrend |
PVCT Free Analysis |
|
PVCT Important Levels Intraday
RESISTANCE | 0.12 |
RESISTANCE | 0.12 |
RESISTANCE | 0.12 |
RESISTANCE | 0.12 |
RESISTANCE | 0.12 |
RESISTANCE | 0.12 |
RESISTANCE | 0.12 |
RESISTANCE | 0.12 |
PVCT Forecast December 2024
4th UP Forecast | 0.18 |
3rd UP Forecast | 0.16 |
2nd UP Forecast | 0.15 |
1st UP Forecast | 0.14 |
1st DOWN Forecast | 0.1 |
2nd DOWN Forecast | 0.09 |
3rd DOWN Forecast | 0.08 |
4th DOWN Forecast | 0.06 |
PVCT Weekly Forecast
4th UP Forecast | 0.18 |
3rd UP Forecast | 0.16 |
2nd UP Forecast | 0.15 |
1st UP Forecast | 0.14 |
1st DOWN Forecast | 0.10 |
2nd DOWN Forecast | 0.09 |
3rd DOWN Forecast | 0.08 |
4th DOWN Forecast | 0.06 |
PVCT Forecast2024
4th UP Forecast | 0.47 |
3rd UP Forecast | 0.36 |
2nd UP Forecast | 0.29 |
1st UP Forecast | 0.22 |
1st DOWN Forecast | 0.02 |
2nd DOWN Forecast | -0.05 |
3rd DOWN Forecast | -0.12 |
4th DOWN Forecast | -0.23 |
Provectus Biopharmaceuticals Inc ( OTCQB USA Symbol : PVCT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PVCT Other Details
Segment | EQ | |
Market Capital | 23359686.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
PVCT Address
PVCT Latest News
PVCT Business Profile
Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing immunotherapy medicines based on halogenated xanthenes. It develops PV-10, an investigational autolytic cancer immunotherapy for adult solid tumor cancers, such as melanoma and gastrointestinal tumors, including hepatocellular carcinoma; colorectal cancer metastatic to the liver; neuroendocrine tumors metastatic to the liver; uveal melanoma metastatic to the liver; and pediatric solid tumor cancers, such as neuroblastoma, Ewing sarcoma, rhabdomyosarcoma, and osteosarcoma. The company is also developing oral formulations of current good manufacturing practice rose bengal disodium (cGMP RBD) for the treatment of adult solid tumor cancers, such as head and neck, breast, pancreatic, liver, and colorectal cancers; pediatric blood cancers, including leukemia; coronavirus, an acute respiratory syndrome; and multi-drug resistant bacteria, such as gram-negative bacteria; and for eye diseases, including infectious keratitis. In addition, it develops PH-10, an investigational immuno-dermatology agent for the treatment of inflammatory dermatoses, such as psoriasis and atopic dermatitis. The company was formerly known as Provectus Pharmaceuticals, Inc. and changed its name to Provectus Biopharmaceuticals, Inc. in December 2013. Provectus Biopharmaceuticals, Inc. was founded in 2002 and is based in Knoxville, Tennessee. Address: 10025 Investment Drive, Knoxville, TN, United States, 37932
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service